<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="levels as well as beneficial effects of hPGDS inhibition in" exact="allergic asthma," post="rhinitis, atopic dermatitis, food allergy, gastrointestinal allergic disorders and"/>
 <result pre="as beneficial effects of hPGDS inhibition in allergic asthma, rhinitis," exact="atopic dermatitis," post="food allergy, gastrointestinal allergic disorders and anaphylaxis. hPGDS hPGDS"/>
 <result pre="effects of hPGDS inhibition in allergic asthma, rhinitis, atopic dermatitis," exact="food allergy," post="gastrointestinal allergic disorders and anaphylaxis. hPGDS hPGDS inhibitor PGD"/>
 <result pre="the pro-inflammatory lipid mediator Prostaglandin D 2 (PGD 2) in" exact="allergy" post="development and progression [ 1, 2, 3]. PGD 2"/>
 <result pre="but DP1 antagonists have also been found to ameliorate rhinitis," exact="conjunctivitis" post="and pulmonary inflammation in animal models [ 8, 9,"/>
 <result pre="it has been reported that in acute inflammation, i.e., experimental" exact="dermatitis" post="[ 12] and colitis [ 13], lipopolysaccharide-induced pulmonary inflammation"/>
 <result pre="that in acute inflammation, i.e., experimental dermatitis [ 12] and" exact="colitis" post="[ 13], lipopolysaccharide-induced pulmonary inflammation [ 14] as well"/>
 <result pre="in African Americans, which seems to be associated with reduced" exact="colorectal cancer" post="risk. However, whether different hPGDS variants are associated with"/>
 <result pre="African Americans, which seems to be associated with reduced colorectal" exact="cancer" post="risk. However, whether different hPGDS variants are associated with"/>
 <result pre="with increased abundance in asthmatic patients, inflammatory bowel disease and" exact="atopic dermatitis" post="[ 35, 36, 37]. A transcriptional signature approach revealed"/>
 <result pre="increased abundance in asthmatic patients, inflammatory bowel disease and atopic" exact="dermatitis" post="[ 35, 36, 37]. A transcriptional signature approach revealed"/>
 <result pre="PGD 2 metabolite, proved to be a specific biomarker for" exact="food allergy" post="in patients [ 41, 42]. Higher levels of hPGDS"/>
 <result pre="2 metabolite, proved to be a specific biomarker for food" exact="allergy" post="in patients [ 41, 42]. Higher levels of hPGDS"/>
 <result pre="also be found in the nasal mucosa of patients with" exact="allergic rhinitis," post="where mast cells could be identified as hPGDS +"/>
 <result pre="Similarly, infiltrating eosinophils in the nasal mucosa of patients with" exact="allergic rhinitis" post="express hPGDS [ 43]. Interestingly, Feng et al. observed"/>
 <result pre="infiltrating eosinophils in the nasal mucosa of patients with allergic" exact="rhinitis" post="express hPGDS [ 43]. Interestingly, Feng et al. observed"/>
 <result pre="observed that human peripheral blood eosinophils from patients with aspirin-exacerbated" exact="respiratory disease" post="express significantly higher levels of hPGDS on protein and"/>
 <result pre="eosinophils, have attracted notice in allergic responses including systemic anaphylaxis," exact="atopic dermatitis," post="allergic rhinitis and asthma [ 51, 52, 53, 54,"/>
 <result pre="attracted notice in allergic responses including systemic anaphylaxis, atopic dermatitis," exact="allergic rhinitis" post="and asthma [ 51, 52, 53, 54, 55]. Via"/>
 <result pre="notice in allergic responses including systemic anaphylaxis, atopic dermatitis, allergic" exact="rhinitis" post="and asthma [ 51, 52, 53, 54, 55]. Via"/>
 <result pre="allergic responses including systemic anaphylaxis, atopic dermatitis, allergic rhinitis and" exact="asthma" post="[ 51, 52, 53, 54, 55]. Via DP2/CRTH2, PGD"/>
 <result pre="56]. Recently, another group addressed the role of basophils in" exact="systemic lupus erythematosus" post="development and found that autocrine PGD 2 production and"/>
 <result pre="Recently, another group addressed the role of basophils in systemic" exact="lupus erythematosus" post="development and found that autocrine PGD 2 production and"/>
 <result pre="addition, increased numbers of activated neutrophils in nasal mucosa of" exact="allergic rhinitis" post="patients exhibit T-cell priming capacity and facilitate eosinophil migration"/>
 <result pre="increased numbers of activated neutrophils in nasal mucosa of allergic" exact="rhinitis" post="patients exhibit T-cell priming capacity and facilitate eosinophil migration"/>
 <result pre="and antigen presentation fully activates allergen-specific T-cells in Birch pollen" exact="allergy" post="[ 60, 61]. In the context of PGD 2,"/>
 <result pre="24 h post stimulation [ 65]. Further, infants who developed" exact="food allergy" post="within the first year of life displayed higher number"/>
 <result pre="h post stimulation [ 65]. Further, infants who developed food" exact="allergy" post="within the first year of life displayed higher number"/>
 <result pre="macrophages as mediators of inflammation has been reviewed vastly in" exact="allergic asthma" post="[ 70], food allergy [ 71] and atopic dermatitis"/>
 <result pre="as mediators of inflammation has been reviewed vastly in allergic" exact="asthma" post="[ 70], food allergy [ 71] and atopic dermatitis"/>
 <result pre="inflammation has been reviewed vastly in allergic asthma [ 70]," exact="food allergy" post="[ 71] and atopic dermatitis [ 72]. Human macrophages"/>
 <result pre="has been reviewed vastly in allergic asthma [ 70], food" exact="allergy" post="[ 71] and atopic dermatitis [ 72]. Human macrophages"/>
 <result pre="in allergic asthma [ 70], food allergy [ 71] and" exact="atopic dermatitis" post="[ 72]. Human macrophages express both DP receptors and"/>
 <result pre="allergic asthma [ 70], food allergy [ 71] and atopic" exact="dermatitis" post="[ 72]. Human macrophages express both DP receptors and"/>
 <result pre="expression in macrophages was reported in the nasal mucosa of" exact="allergic rhinitis" post="patients [ 43], pulmonary macrophages in acute respiratory distress"/>
 <result pre="in macrophages was reported in the nasal mucosa of allergic" exact="rhinitis" post="patients [ 43], pulmonary macrophages in acute respiratory distress"/>
 <result pre="mucosa of allergic rhinitis patients [ 43], pulmonary macrophages in" exact="acute respiratory distress syndrome" post="[ 11] and human adipose tissue macrophages [ 76]."/>
 <result pre="DCs as well as tissue plasmacytoid and myeloid DCs in" exact="atopic dermatitis" post="patients stained positive for hPGDS [ 82]. They could"/>
 <result pre="as well as tissue plasmacytoid and myeloid DCs in atopic" exact="dermatitis" post="patients stained positive for hPGDS [ 82]. They could"/>
 <result pre="could be found in the circulation and skin lesions of" exact="atopic dermatitis" post="patients, and transcriptional profiling of Th2 cells from asthmatic"/>
 <result pre="be found in the circulation and skin lesions of atopic" exact="dermatitis" post="patients, and transcriptional profiling of Th2 cells from asthmatic"/>
 <result pre="disease [ 92]. In a neonatal mouse model of viral" exact="bronchiolitis" post="it could be shown that bronchial epithelial cells constitutively"/>
 <result pre="as well as various respiratory inflammatory syndromes [ 95]. In" exact="atopic dermatitis," post="epidermal keratinocytes have been linked to drive Th2-mediated inflammation"/>
 <result pre="more evidence that angiogenesis may be an early step in" exact="asthma" post="initiation [ 99, 100]. No studies to date could"/>
 <result pre="asthmatics, new drugs are needed for severe and poorly controlled" exact="asthma" post="to effectively replace oral corticosteroids [ 108]. PGD 2"/>
 <result pre="by DP2/CRTH2 activation [ 54]. The role of DP1 in" exact="asthma" post="remains elusive; however, in preclinical models of asthma and"/>
 <result pre="DP1 in asthma remains elusive; however, in preclinical models of" exact="asthma" post="and acute lung injury, DP1 agonism attenuated type 2"/>
 <result pre="have emerged as potential drug targets for the treatment of" exact="allergic asthma" post="[ 22, 114, 115, 116, 117]. In combination with"/>
 <result pre="emerged as potential drug targets for the treatment of allergic" exact="asthma" post="[ 22, 114, 115, 116, 117]. In combination with"/>
 <result pre="infections have been associated with a higher likelyhood of developing" exact="asthma" post="as well as disease progression and acute asthmatic exacerbations"/>
 <result pre="via DP2/CRTH2 from the bloodstream [ 48, 54]. In aspirin-exacerbated" exact="respiratory disease," post="hPGDS-expressing eosinophils seem to contribute to elevated PGD 2"/>
 <result pre="As potent drivers of type-2 inflammation and their role in" exact="allergic asthma," post="ILC-2s have been of great interest lately. Inhibition of"/>
 <result pre="IL-13 production as well as CD25 upregulation [ 84]. In" exact="allergic rhinitis," post="hPGDS but not LPGDS expression could be detected in"/>
 <result pre="effect was due to reduction of PGD 2 synthesis. Severe" exact="asthma" post="often involves airway remodelling including smooth muscle cell hyper-proliferation"/>
 <result pre="2 biosynthesis could be beneficial to delay the onset of" exact="allergic asthma," post="reduce eosinophilic and Th2 type inflammation, alleviate symptoms including"/>
 <result pre="asthma, reduce eosinophilic and Th2 type inflammation, alleviate symptoms including" exact="allergic rhinitis" post="and cough as well as reduce airway remodelling. 4.2."/>
 <result pre="reduce eosinophilic and Th2 type inflammation, alleviate symptoms including allergic" exact="rhinitis" post="and cough as well as reduce airway remodelling. 4.2."/>
 <result pre="as well as reduce airway remodelling. 4.2. Atopic Dermatitis Atopic" exact="dermatitis" post="is a chronic inflammatory skin disease which affects up"/>
 <result pre="major components of disease development and progression [ 122]. In" exact="atopic dermatitis," post="Langerhans cells, plasmatoid and myeloid dendritic cells express hPGDS"/>
 <result pre="like bacterial LPS [ 82]. In addition, epidermal keratinocytes of" exact="atopic dermatitis" post="patients are also able to produce LPGDS-derived PGD 2,"/>
 <result pre="bacterial LPS [ 82]. In addition, epidermal keratinocytes of atopic" exact="dermatitis" post="patients are also able to produce LPGDS-derived PGD 2,"/>
 <result pre="via DP2/CRTH2 receptor in the late phase in croton oil-induced" exact="dermatitis" post="in mice [ 12]. In this study, transgenic hPGDS"/>
 <result pre="Th2 cell numbers as well as inflammatory cytokine levels in" exact="atopic dermatitis" post="lesions. 4.3. Food Allergy and Gastrointestinal Allergic Disorder The"/>
 <result pre="cell numbers as well as inflammatory cytokine levels in atopic" exact="dermatitis" post="lesions. 4.3. Food Allergy and Gastrointestinal Allergic Disorder The"/>
 <result pre="PGD 2 metabolite tetranor-PGDM can be found in patients with" exact="food allergy" post="but not in those with other allergic diseases or"/>
 <result pre="2 metabolite tetranor-PGDM can be found in patients with food" exact="allergy" post="but not in those with other allergic diseases or"/>
 <result pre="see that OVA-induced intestinal allergic inflammation as well as milk-induced" exact="food allergy" post="in mice resulted in increased urinary tetranor-PGDM, which reflected"/>
 <result pre="that OVA-induced intestinal allergic inflammation as well as milk-induced food" exact="allergy" post="in mice resulted in increased urinary tetranor-PGDM, which reflected"/>
 <result pre="and blocking DP2/CRTH2 with specific antagonists could alleviate symptoms in" exact="eosinophilic esophagitis" post="patients [ 127, 128]. In summary, a reduction of"/>
 <result pre="for hPGDS inhibitors as therapeutic option in allergic inflammation, asthma," exact="chronic obstructive pulmonary disease" post="and other inflammatory diseases have been issued [ 132,"/>
 <result pre="selective and reversible hPGDS inhibitor ZL-2102 for treatment of COPD," exact="asthma" post="and idiopathic pulmonary fibrosis [ 135]. In this clinical"/>
 <result pre="reversible hPGDS inhibitor ZL-2102 for treatment of COPD, asthma and" exact="idiopathic pulmonary fibrosis" post="[ 135]. In this clinical trial, 120 participants were"/>
 <result pre="hPGDS inhibitor ZL-2102 for treatment of COPD, asthma and idiopathic" exact="pulmonary fibrosis" post="[ 135]. In this clinical trial, 120 participants were"/>
 <result pre="pharmacokinetics of hPGDS inhibitor TAS-205 in 23 boys with Duchenne’s" exact="muscular dystrophy" post="could be completed successfully in 2018 [ 136]. Their"/>
 <result pre="and was deemed safe and tolerable in patients with Duchenne’s" exact="muscular dystrophy." post="Urinary PGD-metabolite was significantly reduced following treatment without interfering"/>
 <result pre="that showed beneficial effects of hPGDS inhibitors were conducted in" exact="allergy" post="models ( Figure 2 and Figure 3); type-2 inflammatory"/>
 <result pre="( Figure 2 and Figure 3); type-2 inflammatory disorders like" exact="allergic asthma," post="food allergy, EGID and atopic dermatitis involve similar effector"/>
 <result pre="2 and Figure 3); type-2 inflammatory disorders like allergic asthma," exact="food allergy," post="EGID and atopic dermatitis involve similar effector cell types"/>
 <result pre="type-2 inflammatory disorders like allergic asthma, food allergy, EGID and" exact="atopic dermatitis" post="involve similar effector cell types that react strongly to"/>
 <result pre="inflammatory disorders like allergic asthma, food allergy, EGID and atopic" exact="dermatitis" post="involve similar effector cell types that react strongly to"/>
 <result pre="PGD metabolite has been associated with worse prognosis in Aspirin-exacerbated" exact="respiratory disease" post="[ 138]. TAS-205 has been shown to efficiently reduce"/>
 <result pre="Lambrecht B.N. Activation of the D prostanoid 1 receptor suppresses" exact="asthma" post="by modulation of lung dendritic cell function and induction"/>
 <result pre="prostaglandin D 2 is an early anti-inflammatory signal in experimental" exact="colitis" post="Am. J. Physiol. Liver Physiol. 2000 279 G238 G244"/>
 <result pre="Y. et al. Prostaglandin D 2 as a mediator of" exact="allergic asthma" post="Science 2000 287 2013 2017 10.1126/science.287.5460.2013 10720327 19. Scher"/>
 <result pre="et al. Prostaglandin D 2 as a mediator of allergic" exact="asthma" post="Science 2000 287 2013 2017 10.1126/science.287.5460.2013 10720327 19. Scher"/>
 <result pre="Jandl K. Heinemann A. The therapeutic potential of CRTH2/DP2 beyond" exact="allergy" post="and asthma Prostaglandins Other Lipid Mediat. 2017 3 42"/>
 <result pre="Heinemann A. The therapeutic potential of CRTH2/DP2 beyond allergy and" exact="asthma" post="Prostaglandins Other Lipid Mediat. 2017 3 42 48 10.1016/j.prostaglandins.2017.08.006"/>
 <result pre="Kabashima K. Narumiya S. The DP receptor, allergic inflammation and" exact="asthma" post="Prostaglandins Leukot. Essent. Fat. Acids 2003 69 187 194"/>
 <result pre="common among African Americans and its relationship to risk for" exact="colorectal cancer" post="Prostaglandins Other Lipid Mediat. 2012 97 22 28 10.1016/j.prostaglandins.2011.07.006"/>
 <result pre="among African Americans and its relationship to risk for colorectal" exact="cancer" post="Prostaglandins Other Lipid Mediat. 2012 97 22 28 10.1016/j.prostaglandins.2011.07.006"/>
 <result pre="T. Kimura M. Wilson B.S. Kawakami Y. Mast cells in" exact="atopic dermatitis" post="Curr. Opin. Immunol. 2009 21 666 678 10.1016/j.coi.2009.09.006 19828304"/>
 <result pre="Kimura M. Wilson B.S. Kawakami Y. Mast cells in atopic" exact="dermatitis" post="Curr. Opin. Immunol. 2009 21 666 678 10.1016/j.coi.2009.09.006 19828304"/>
 <result pre="Murata T. Prostaglandin D2metabolite in urine is an index of" exact="food allergy" post="Sci. Rep. 2017 7 1 8 10.1038/s41598-017-17798-w 28127051 42."/>
 <result pre="T. Prostaglandin D2metabolite in urine is an index of food" exact="allergy" post="Sci. Rep. 2017 7 1 8 10.1038/s41598-017-17798-w 28127051 42."/>
 <result pre="of prostaglandin D2–related molecules in nasal mucosa of patients with" exact="allergic rhinitis" post="Am. J. Rhinol. 2006 20 342 348 10.2500/ajr.2006.20.2865 16871941"/>
 <result pre="prostaglandin D2–related molecules in nasal mucosa of patients with allergic" exact="rhinitis" post="Am. J. Rhinol. 2006 20 342 348 10.2500/ajr.2006.20.2865 16871941"/>
 <result pre="H. Prostagladin D2 is a mast cell-derived antiangiogenic factor in" exact="lung carcinoma" post="Proc. Natl. Acad. Sci. USA 2011 108 19802 19807"/>
 <result pre="Immunohistochemical detection of human basophils in postmortem cases of fatal" exact="asthma" post="Am. J. Respir. Crit. Care Med. 2001 164 1053"/>
 <result pre="Georén S. Cardell L.O. A possible role for neutrophils in" exact="allergic rhinitis" post="revealed after cellular subclassification Sci. Rep. 2017 7 1"/>
 <result pre="S. Cardell L.O. A possible role for neutrophils in allergic" exact="rhinitis" post="revealed after cellular subclassification Sci. Rep. 2017 7 1"/>
 <result pre="P. Jahn-Schmid B. Bohle B. Neutrophils promote T-cell-mediated inflammation in" exact="allergy" post="J. Allergy Clin. Immunol. 2018 143 1923 1925 10.1016/j.jaci.2018.11.035"/>
 <result pre="induce nonclassic &quot;T H 2-type&quot; immunity associated with development of" exact="food allergy" post="Sci. Transl. Med. 2016 8 321ra8 10.1126/scitranslmed.aad4322 26764159 67."/>
 <result pre="nonclassic &quot;T H 2-type&quot; immunity associated with development of food" exact="allergy" post="Sci. Transl. Med. 2016 8 321ra8 10.1126/scitranslmed.aad4322 26764159 67."/>
 <result pre="N.H. van den Berge M. Postma D.S. Melgert B.N. Human" exact="asthma" post="is characterized by more IRF5+ M1 and CD206+ M2"/>
 <result pre="S. Werfel T. Role of macrophages in the pathogenesis of" exact="atopic dermatitis" post="Mediators Inflamm. 2013 2013 1 15 10.1155/2013/942375 23533313 73."/>
 <result pre="Werfel T. Role of macrophages in the pathogenesis of atopic" exact="dermatitis" post="Mediators Inflamm. 2013 2013 1 15 10.1155/2013/942375 23533313 73."/>
 <result pre="concentrations in dendritic cells induce and regulate Th2 immunity and" exact="allergic asthma" post="Proc. Natl. Acad. Sci. USA 2015 112 1529 1534"/>
 <result pre="in dendritic cells induce and regulate Th2 immunity and allergic" exact="asthma" post="Proc. Natl. Acad. Sci. USA 2015 112 1529 1534"/>
 <result pre="James M. Fletcher J. Cleland L.G. Prostaglandin D(2) in inflammatory" exact="arthritis" post="and its relation with synovial fluid dendritic cells Mediators"/>
 <result pre="Upham J.W. et al. PGD2/DP2 receptor activation promotes severe viral" exact="bronchiolitis" post="by suppressing IFN- production Sci. Transl. Med. 2018 10"/>
 <result pre="in the innate response to allergens and initiation of atopic" exact="asthma" post="J. Clin. Invest. 2018 128 3116 3128 10.1172/JCI97720 29911993"/>
 <result pre="Augmented Pla2g4c/Ptgs2/Hpgds axis in bronchial smooth muscle tissues of experimental" exact="asthma" post="PLoS ONE 2018 13 e0202623 10.1371/journal.pone.0202623 30161143 104. Chen"/>
 <result pre="Zhang J. et al. Inhibition of CRTH2-mediated Th2 activation attenuates" exact="pulmonary hypertension" post="in mice J. Exp. Med. 2018 215 2175 2195"/>
 <result pre="Holguin F. Wenzel S.E. Prostaglandin D2 pathway upregulation: Relation to" exact="asthma" post="severity, control, and TH2 inflammation J. Allergy Clin. Immunol."/>
 <result pre="receptor antagonists in early development as potential therapeutic options for" exact="asthma" post="Expert Opin. Investig. Drugs 2016 25 1083 1092 10.1080/13543784.2016.1212838"/>
 <result pre="E.M. Mitchel E.F. Sloan C. Hartert T.V. Risk of childhood" exact="asthma" post="following infant bronchiolitis during the respiratory syncytial virus season"/>
 <result pre="Sloan C. Hartert T.V. Risk of childhood asthma following infant" exact="bronchiolitis" post="during the respiratory syncytial virus season J. Allergy Clin."/>
 <result pre="in biphasic nasal obstruction in guinea pig model of experimental" exact="allergic rhinitis" post="Eur. J. Pharmacol. 2011 667 389 395 10.1016/j.ejphar.2011.05.041 21645503"/>
 <result pre="biphasic nasal obstruction in guinea pig model of experimental allergic" exact="rhinitis" post="Eur. J. Pharmacol. 2011 667 389 395 10.1016/j.ejphar.2011.05.041 21645503"/>
 <result pre="C. Mann J. New insights into the epidemiology of childhood" exact="atopic dermatitis" post="Allergy 2014 69 3 16 10.1111/all.12270 24417229 122. Hajar"/>
 <result pre="Mann J. New insights into the epidemiology of childhood atopic" exact="dermatitis" post="Allergy 2014 69 3 16 10.1111/all.12270 24417229 122. Hajar"/>
 <result pre="T. Gontijo J.R.V. Hanifin J.M. New and developing therapies for" exact="atopic dermatitis" post="An. Bras. Dermatol. 2018 93 104 107 10.1590/abd1806-4841.20187682 29641707"/>
 <result pre="Gontijo J.R.V. Hanifin J.M. New and developing therapies for atopic" exact="dermatitis" post="An. Bras. Dermatol. 2018 93 104 107 10.1590/abd1806-4841.20187682 29641707"/>
 <result pre="activity and clinical efficacy of the CRTH2 antagonist OC000459 in" exact="eosinophilic esophagitis" post="Allergy 2013 68 375 385 10.1111/all.12096 23379537 129. Simons"/>
 <result pre="A phase I study of TAS-205 in patients with Duchenne" exact="muscular dystrophy" post="Ann. Clin. Transl. Neurol. 2018 5 1338 1349 10.1002/acn3.651"/>
 <result pre="J.A. Laidlaw T.M. Prostaglandin D2: A dominant mediator of aspirin-exacerbated" exact="respiratory disease" post="J. Allergy Clin. Immunol. 2015 135 245 252 10.1016/j.jaci.2014.07.031"/>
 <result pre="[ 119] TAS-205 not reported Taiho Pharmaceutical Co. Ltd. Duchenne‘s" exact="muscular dystrophy" post="(Phase I) 1.67–13.33 mg/kg/dose [ 136] KMN-698 not reported"/>
</results>
